Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus
Clinical trial NCT01862965 · COMPLETED
Trial details
- NCT number
- NCT01862965
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-06
- Primary completion
- 2018-02-07
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.